DexCom (DXCM) Tops Q3 EPS by 4c
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $89.35 +1.61%
EPS Growth %: +9.8%
Financial Fact:
Interest expense: -200K
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: +9.8%
Financial Fact:
Interest expense: -200K
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
DexCom (NASDAQ: DXCM) reported Q3 EPS of $0.28, $0.04 better than the analyst estimate of $0.24. Revenue for the quarter came in at $769.6 million versus the consensus estimate of $751.74 million.
GUIDANCE:
DexCom sees Q4 2022 revenue of $2.88-2.91 billion, versus the consensus of $2.89 billion.
For earnings history and earnings-related data on DexCom (DXCM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Lumentum shares rise on analyst upgrades, AI demand outlook
- Forgent Power Solutions, Inc. (FPS) Tops Q2 EPS by 1c, Beats on Revenue; Offers FY27 Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
